Literature DB >> 30561744

Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis.

Thomas A D'Agostino1,2, Abenaa M Brewster3, Susan K Peterson4, Isabelle Bedrosian5, Patricia A Parker1.   

Abstract

Rates of contralateral prophylactic mastectomy (CPM) have risen substantially, yet little is known about how and to what extent CPM is discussed within surgical oncology visits at the time of treatment decision-making. We examined CPM discussions in naturally occurring interactions between sporadic breast cancer patients and their surgical oncology providers. Women with early-stage unilateral disease were recruited before their first surgical visit and completed brief questionnaires to determine study eligibility and interest in treatment options. After their visits, enrolled patients and their providers completed questionnaires assessing discussion of and interest in CPM. Audio-recorded visits from 36 unique patients were randomly selected, transcribed, and analyzed. A CPM discussion was present in 28 transcripts. Approximately half of CPM discussions were initiated by the patient or the oncology provider. The topic of CPM was most frequently introduced while reviewing available treatment options. Patients were most interested in pursuing CPM to reduce the risk of future breast cancer. Providers most frequently responded by offering information (e.g., about risk of contralateral disease). A high level of agreement was found among patient, provider, and observer ratings of whether or not CPM was discussed. CPM discussions were consistently present within our sample. Results can be used to build providers' skills and bring provider-patient communication more in line with best practices and recommendations from leading professional medical societies. © Society of Behavioral Medicine 2018. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  breast cancer; contralateral prophylactic mastectomy; decision making; provider-patient communication; surgery

Mesh:

Year:  2020        PMID: 30561744      PMCID: PMC7237543          DOI: 10.1093/tbm/iby098

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.046


  48 in total

1.  Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up.

Authors:  P P Rosen; S Groshen; D W Kinne; S Hellman
Journal:  Surgery       Date:  1989-11       Impact factor: 3.982

2.  Helping patients decide: ten steps to better risk communication.

Authors:  Angela Fagerlin; Brian J Zikmund-Fisher; Peter A Ubel
Journal:  J Natl Cancer Inst       Date:  2011-09-19       Impact factor: 13.506

3.  Provider perspectives on presenting risk information and managing worry about recurrence among breast cancer survivors.

Authors:  Nancy K Janz; Rebecca L Leinberger; Brian J Zikmund-Fisher; Sarah T Hawley; Kent Griffith; Reshma Jagsi
Journal:  Psychooncology       Date:  2014-07-23       Impact factor: 3.894

4.  Clinical and histological predictors of contralateral breast cancer.

Authors:  J Kollias; I O Ellis; C W Elston; R W Blamey
Journal:  Eur J Surg Oncol       Date:  1999-12       Impact factor: 4.424

5.  How well do doctors know their patients? Factors affecting physician understanding of patients' health beliefs.

Authors:  Richard L Street; Paul Haidet
Journal:  J Gen Intern Med       Date:  2010-07-23       Impact factor: 5.128

6.  Long-Term Satisfaction and Body Image After Contralateral Prophylactic Mastectomy.

Authors:  Chelsea Anderson; Jessica Y Islam; M Elizabeth Hodgson; Susan A Sabatino; Juan L Rodriguez; Clara N Lee; Dale P Sandler; Hazel B Nichols
Journal:  Ann Surg Oncol       Date:  2017-01-05       Impact factor: 5.344

7.  Bilateral Mastectomy versus Breast-Conserving Surgery for Early-Stage Breast Cancer: The Role of Breast Reconstruction.

Authors:  Claudia R Albornoz; Evan Matros; Clara N Lee; Clifford A Hudis; Andrea L Pusic; Elena Elkin; Peter B Bach; Peter G Cordeiro; Monica Morrow
Journal:  Plast Reconstr Surg       Date:  2015-06       Impact factor: 4.730

8.  What is a good medical decision? A research agenda guided by perspectives from multiple stakeholders.

Authors:  Jada G Hamilton; Sarah E Lillie; Dana L Alden; Laura Scherer; Megan Oser; Christine Rini; Miho Tanaka; John Baleix; Mikki Brewster; Simon Craddock Lee; Mary K Goldstein; Robert M Jacobson; Ronald E Myers; Brian J Zikmund-Fisher; Erika A Waters
Journal:  J Behav Med       Date:  2016-08-26

Review 9.  Contralateral prophylactic mastectomy (CPM): A systematic review of patient reported factors and psychological predictors influencing choice and satisfaction.

Authors:  Brittany Ager; Phyllis Butow; Jesse Jansen; Kelly-Anne Phillips; David Porter
Journal:  Breast       Date:  2016-06-09       Impact factor: 4.380

10.  Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.

Authors:  Jack Cuzick; Ivana Sestak; Michael Baum; Aman Buzdar; Anthony Howell; Mitch Dowsett; John F Forbes
Journal:  Lancet Oncol       Date:  2010-11-17       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.